Linagliptin Impurity F

Linagliptin Impurity F is a structurally related degradation byproduct arising from oxidative cleavage of the pyrazine ring in the parent drug. It retains the tetrahydropyridine core but features a desulfonamidated side chain with a terminal carboxylic acid moiety. This impurity serves as a critical HPLC reference standard for quantifying process-related degradation in linagliptin formulations.